ClinicalTrials.govpublic full text
CPX-351 and Glasdegib for Newly Diagnosed Acute Myelogenous Leukemia With MDS Related Changes or Therapy-related Acute Myeloid Leukemia
acute myelogenous leukemia (aml) due to therapy, acute myeloid leukemia with myelodysplasia-related changes, therapy-related aml, aml with mds related changes, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 868640
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.